References
- Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopaty: from bench to the clinics. J Cardiovasc Electrophisiol 2008;19:104-10.
- Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20. https://doi.org/10.1001/jama.287.10.1308
- Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determiants of clinical disease expression. Nat Clinc Pract Cardiovasc Med 2008;51:158-68.
- Lind JM, Chiu C, Semsarian C. Genetic basis of hypertrophic cardiomyopathy. Expert Rev Cardiovasc Ther 2006;4:927-34. https://doi.org/10.1586/14779072.4.6.927
- Arad M, Maron BJ, Gorham JM, Johnson WH, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG. Glycogen storage disease presenting as hypertrophic cardiomyopathy. N Emgl J Med 2005;352:362-72. https://doi.org/10.1056/NEJMoa033349
- Danon MJ, Oh SH, Di Mauro S, Manaligod JR, Eastwood A, Naidu S. Lysosomal glycogen storage disease with normal acid maltase. Neurology 1981;31:51-7. https://doi.org/10.1212/WNL.31.1.51
- Charron P, Villard E, Sebillon P, Laforet P, Maisonobe T, Duboscq-Bidot L, Romero N, Drouin-Garraud V, Frébourg T, Richard P, Eymard B, Komajda M. Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey. Heart 2004;90:842-6. https://doi.org/10.1136/hrt.2003.029504
- Sugie K, Yamamoto A, Murayama BS, Oh SJ, Takahashi M, Mora M, Riggs JE, Colomer J, Iturriaga C, Meloni A, Lamperti C, Saitoh S, Byrne E, DiMauro S, Nonaka I, Hirano M, Nishino I. Clinicopathological feature of genetically confirmed Danon disease. Neurology 2002;58:1773-8. https://doi.org/10.1212/WNL.58.12.1773
- Fanin M, Nascimbeni AC, Fulizio L, Spinazzi M, Melacini P, Anqelini C. Generalized Lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease. Am J Pathol 2006;168:1309-20. https://doi.org/10.2353/ajpath.2006.050646
- Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, Mora M, Riggs JE, Oh SJ, Koga Y, Sue CM, Yamamoto A, Murakami N, Shanske S, Byme E, Bonilla E, Nonaka I, DiMauro S, Hirano M. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 2000;406:906-10. https://doi.org/10.1038/35022604
- Sugimoto S, Shiomi K, Yamamoto A, Nishino I, Nonaka I, Ohi T. LAMP-2 positive vacuolar myopahty with dilated cardiomyopathy. Intern Med 2007;46:757-60. https://doi.org/10.2169/internalmedicine.46.6265
- Taylor MR, Ku L, Slavov D, Cavanaugh j, Boucek M, Zhu X, Carniel E, Barnes C, Quan D, Prall R, Lovell MA, Mierau G, Ruegg P, Mandava N, Bristow MR, Towbin JA, Mestroni L. Danon disease presenting with dilated cardiomyopathy and a complex phenotype. J Hum Genet 2007;52:830-5. https://doi.org/10.1007/s10038-007-0184-8
- Christine S. Genetic cause of inherited cardiac hypertrophy. Mayo Clin Proc 2002;77:1315-9. https://doi.org/10.4065/77.12.1315
- Arad M, Benson DW, perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ, McGarry K, Seidman JG, Seidman CE. Constitutive active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 2002;109:357-62. https://doi.org/10.1172/JCI0214571
- Beer G, Reinecke P, Gabbert HE, Hort W, Kuhn H. Fabry disease in patients with hypertrophic cardiomyopathy (HCM). Z Kardiol 2002;91:992-1002. https://doi.org/10.1007/s00392-002-0870-7